Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia
Clinical trial NCT06955104 · COMPLETED
Trial details
- NCT number
- NCT06955104
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-03
- Primary completion
- 2025-07-30
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.